Marcaine 0.5% Injection

Страна: Йорданія

мова: англійська

Джерело: JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

Активний інгредієнт:

Bupivacaine Hcl 0.5 %

Доступна з:

مستودع ادوية شاوي و رشيدات و مسنات - Shawi & Rushedat Drug Store

Код атс:

N01BB01

ІПН (Міжнародна Ім'я):

Bupivacaine Hcl 0.5 %

Дозування:

0.5%

Одиниць в упаковці:

5 Vail X 20 ml

Виробник:

Recipharm Monts (فرنسا)

інформаційний буклет

M120212AA
MARCAINE 0.5%
COMPOSITION
MARCAINE ADRENALINE 0.5%
_bupivacaine hydrochloride _
SOLUTION FOR INJECTION
Experience to date indicates that 400 mg
Marcaine, solution for injection: 1 ml contains:
bupivacaine hydrochloride 5.0 mg.
Marcaine adrenaline, solution for injection:
1 ml contains: bupivacaine hydrochloride 5.0 mg +
adrenaline 5 microg/ml.
For excipients, see List of excipients.
PHARMACEUTICAL FORM
Solution for injection.
THERAPEUTIC INDICATIONS
Bupivacaine can be used for a number of anaesthetic
techniques, including local infiltration, minor and major
nerve blocks and epidural block.
POSOLOGY AND METHOD OF ADMINISTRATION
_Adults and children above 12 years of age _
The following table is a guide to dosage for the more
commonly used techniques. The clinician's experience
and knowledge of the patient's physical status are of
importance in calculating the required dose. When
prolonged blocks are used, either by continuous
infusion or by repeated bolus administration, the risks
of reaching a toxic plasma concentration or inducing a
local neural injury must be considered.
DOSAGE RECOMMENDATIONS FOR ADULTS
Remarks:
1)
Dose includes test dose
2)
The dose for a major nerve block must be adjusted
according to site of administration and patient status.
Interscalene and supraclavicular brachial plexus blocks
may be associated with a higher frequency of serious
adverse reactions, regardless of the local anaesthetic used
(see section Special warnings and precautions for use)
3)
Marcaine without adrenaline
The doses in the table are those considered to be
necessary to produce a successful block and should
be regarded as a guide for use in adults. Individual
variations in onset and duration occur. The figures
reflect the expected average dose range needed.
Standard textbooks should be consulted for factors
affecting specific block techniques and for individual
patient requirements. N.B. Risk of systemic effects
of adrenaline with large volumes of adrenaline
containing solutions should be considered
_. _
In order